Literature DB >> 8628473

Linkage and mutation analysis of Charcot-Marie-Tooth neuropathy type 2 families with chromosomes 1p35-p36 and Xq13.

V Timmerman1, P De Jonghe, P Spoelders, S Simokovic, A Löfgren, E Nelis, J Vance, J J Martin, C Van Broeckhoven.   

Abstract

A locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2A) was assigned by linkage analysis to chromosome 1p35-p36. We examined 11 unrelated CMT2 families for linkage to CMT2A using short tandem repeat (STR) polymorphisms. Only one family showed suggestive evidence for linkage to 1p35-p36. Further, because of an overlap in electrophysiologic data between CMT2 and CMTX female patients, we screened 6 of 11 CMT2 families compatible with dominant X-linkage for mutations in the connexin 32 (Cx32) gene at Xq13. There was a Cx32 mutation in one family, whereas another family showed suggestive evidence for Xq13 linkage upon analysis with STR polymorphisms. Our results suggest that the CMT2A locus is a minor locus for CMT2, additional linkage studies are needed to localize other CMT2 loci, and Cx32 mutations may be the underlying genetic defect in some CMT2 families.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8628473     DOI: 10.1212/wnl.46.5.1311

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.

Authors:  I V Mersiyanova; A V Perepelov; A V Polyakov; V F Sitnikov; E L Dadali; R B Oparin; A N Petrin; O V Evgrafov
Journal:  Am J Hum Genet       Date:  2000-06-07       Impact factor: 11.025

2.  A second locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 19q13.3.

Authors:  A Leal; B Morera; D Heuss; C Kayser; M Berghoff; R Villegas; E Hernández; M Méndez; H C Hennies; B Neundörfer; R Barrantes; A Reis; B Rautenstrauss
Journal:  Am J Hum Genet       Date:  2000-12-07       Impact factor: 11.025

Review 3.  Molecular genetics of X-linked Charcot-Marie-Tooth disease.

Authors:  Kleopas A Kleopa; Steven S Scherer
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

4.  Mutilating neuropathic ulcerations in a chromosome 3q13-q22 linked Charcot-Marie-Tooth disease type 2B family.

Authors:  P De Jonghe; V Timmerman; D FitzPatrick; P Spoelders; J J Martin; C Van Broeckhoven
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

5.  Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32.

Authors:  P Anzini; D H Neuberg; M Schachner; E Nelles; K Willecke; J Zielasek; K V Toyka; U Suter; R Martini
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

6.  Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice.

Authors:  R Frei; S Mötzing; I Kinkelin; M Schachner; M Koltzenburg; R Martini
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

7.  The first de novo mutation of the connexin 32 gene associated with X linked Charcot-Marie-Tooth disease.

Authors:  F Meggouh; A Benomar; H Rouger; S Tardieu; N Birouk; J Tassin; C Barhoumi; M Yahyaoui; T Chkili; A Brice; E LeGuern
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

8.  Axonal Charcot-Marie-Tooth disease and the neurofilament light gene (NF-L)

Authors:  J R Lupski
Journal:  Am J Hum Genet       Date:  2000-06-07       Impact factor: 11.025

Review 9.  RNA processing defects associated with diseases of the motor neuron.

Authors:  Stephen J Kolb; Scott Sutton; Daniel R Schoenberg
Journal:  Muscle Nerve       Date:  2010-01       Impact factor: 3.217

10.  A novel mutation of myelin protein zero associated with an axonal form of Charcot-Marie-Tooth disease.

Authors:  L Santoro; F Manganelli; E Di Maria; D Bordo; D Cassandrini; F Ajmar; P Mandich; E Bellone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.